recent
year
coronavirus
receiv
increas
attent
clinic
infecti
diseas
expert
discoveri
coronaviru
etiolog
agent
sever
acut
respiratori
syndrom
sarscov
identif
anoth
coronaviru
caus
upper
respiratori
tract
diseas
children
emphas
import
improv
understand
agent
identif
angiotensinconvert
enzym
cellsurfac
receptor
sarscov
open
field
develop
new
treatment
prophylact
review
describ
discoveri
coronaviru
receptor
interact
coronavir
surfac
protein
light
viral
entri
process
host
tropism
viral
order
nidoviral
group
numer
virus
vertebr
invertebr
share
common
characterist
genom
organ
transcript
replic
strategi
diseas
manifest
mani
virus
caus
acut
chronic
upper
respiratori
gastrointestin
hepat
neurolog
diseas
human
anim
enjuan
et
al
nidovirus
compartment
three
viral
famili
arterivirida
coronavirida
ronivirida
nidovir
pathogen
infect
human
belong
exclus
famili
coronavirida
contain
two
genera
coronaviru
toroviru
enjuan
et
al
coronavirus
sensu
stricto
virus
belong
genu
coronaviru
rather
member
famili
coronavirida
spheric
slightli
pleomorph
virus
diamet
virion
strand
rna
posit
polar
helic
encapsid
nucleocapsid
n
protein
enjuan
et
al
filament
ribonucleocapsid
surround
matrix
protein
form
icosahedr
core
core
wrap
envelop
form
coronavir
bud
host
cell
membran
contain
distinct
clubor
petalshap
protrus
identifi
spike
protein
protein
give
virion
crownlik
appear
latin
corona
electron
microscop
imag
enjuan
et
al
protein
major
antigen
determin
coronavirus
daniel
et
al
gallagh
et
al
koo
et
al
moor
et
al
song
et
al
coronavirus
attach
cellsurfac
receptor
via
protein
mediat
fusion
hostcel
membran
subsequ
nest
set
subgenom
rna
produc
genom
replic
occur
cytoplasm
result
highfrequ
recombin
replic
matur
coronavirus
bud
endoplasm
reticulumgolgi
intermedi
compart
enjuan
et
al
three
distinct
genet
serolog
group
coronavirus
acknowledg
group
undergo
revis
gonzalez
et
al
sever
coronavirus
known
caus
diseas
human
human
coronaviru
group
viru
human
coronaviru
group
viru
caus
mild
upper
respiratori
infect
result
selfresolv
common
cold
otherwis
healthi
individu
sever
pneumonia
immunocompromis
peopl
denison
pene
et
al
human
coronaviru
also
refer
hcovnh
hcovnl
recent
identifi
group
viru
caus
conjunct
sometim
seriou
respiratori
infect
children
esper
et
al
fouchier
et
al
van
der
hoek
et
al
epidemiolog
analys
suggest
viru
associ
kawasaki
diseas
esper
et
al
anoth
group
coronaviru
recent
isol
old
man
pneumonia
woo
et
al
sever
pathogen
human
contain
one
copi
cap
polyadenyl
singlecoronavirus
await
character
mcintosh
sever
acut
respiratori
syndrom
sar
first
describ
novemb
inhabit
guangdong
provinc
peopl
republ
china
present
influenzalik
ill
began
dyspnea
myalgia
pyrexia
often
follow
acut
pneumonia
respiratori
failur
death
novel
diseas
transmit
via
droplet
fomit
direct
contact
patient
uninfect
individu
yu
et
al
outbreak
spread
asia
europ
north
america
end
minipandem
juli
total
case
record
die
cherri
novel
coronaviru
sever
acut
respiratori
syndrom
viru
sarscov
speci
sever
acut
respiratori
syndrom
coronaviru
identifi
etiolog
agent
fouchier
et
al
ksiazek
et
al
kuiken
et
al
mayo
molecular
analys
demonstr
sarscov
cluster
group
coronavirus
gibb
et
al
gorbalenya
et
al
sar
reemerg
guangdong
provinc
infect
four
individu
recov
fleck
song
et
al
case
record
date
trace
back
accident
laboratori
infect
one
two
nonfat
case
respect
record
laboratori
republ
singapor
taiwan
normil
last
case
occur
laboratori
anhui
provinc
nine
case
includ
one
fatal
beij
two
case
peopl
republ
china
natur
reservoir
sarscov
remain
elus
chines
ferretbadg
melogal
moschata
himalayan
palm
civet
paguma
larvata
racoon
dog
nyctereut
procyonoid
suggest
host
candid
carri
sarscovlik
virus
guan
et
al
domest
cat
feli
domesticu
ferret
mustela
putoriu
furo
himalayan
palm
civet
propos
potenti
carrier
suscept
sarscov
infect
transmit
agent
martina
et
al
wu
et
al
balbc
mice
wentworth
et
al
hamster
cynomolgu
rhesu
macaqu
row
et
al
current
use
anim
model
sarscov
infect
today
vaccin
approv
prevent
human
sarscov
infect
although
sever
candid
clinic
evalu
sera
obtain
sar
survivor
contain
high
titer
sarscovneutr
antibodi
sar
patient
report
clinic
improv
administr
reconvalesc
sera
li
et
al
pearson
et
al
neutral
antibodi
administ
balbc
mice
intraperiton
one
day
intranas
challeng
tissu
cultur
infect
dose
tcid
sarscov
urbani
strain
reduc
viral
load
four
order
magnitud
data
suggest
antibodi
could
use
prevent
treat
sar
also
develop
sar
vaccin
plausibl
promis
result
vaccin
develop
obtain
inactiv
whole
viru
et
al
takasuka
et
al
recombin
n
protein
administ
either
dna
vaccin
yang
et
al
zhao
et
al
via
replicationdefici
adenovirus
zakhartchouk
et
al
lactococcu
lacti
pei
antibodi
report
immun
major
vaccin
protect
mice
challeng
infecti
sarscov
howev
mice
develop
sarslik
diseas
viral
infect
sarscov
infect
lead
high
level
replic
respiratori
tract
viru
clear
within
seven
day
post
infect
henc
remain
unclear
whether
vaccin
candid
test
would
also
efficaci
primat
later
human
studi
nonhuman
primat
spars
least
one
group
achiev
protect
african
green
monkey
chlorocebu
aethiop
sarscov
challeng
vaccin
attenu
parainfluenza
viru
express
sarscov
protein
obviou
target
antivir
agent
includ
sarscov
proteas
mrna
methyltransferas
ntpasehelicas
transcriptasereplicas
complex
howev
except
interferon
shown
effect
inhibit
sarscov
replic
tissu
cultur
clinic
approv
antivir
drug
could
identifi
treatment
sar
far
host
spectrum
virul
specif
coronaviru
larg
determin
protein
kuo
et
al
phillip
et
al
sanchez
et
al
coronavir
protein
measur
nm
length
space
wide
apart
evenli
distribut
surfac
et
al
chen
et
al
case
develop
neutral
et
al
well
via
proteinexpress
vaccinia
virus
bisht
coronavirion
enjuan
et
al
type
transmembran
class
fusion
protein
bosch
et
al
gallagh
consist
distinct
ntermin
ctermin
domain
mediat
receptor
bind
viruscel
fusion
respect
gallagh
upon
bind
cellsurfac
receptor
conform
chang
domain
induc
exposur
fusion
peptid
embed
domain
induc
reorgan
unusu
larg
heptad
repeat
coiledcoil
extrem
conform
switch
forc
virion
membran
close
apposit
cell
membran
allow
fusion
henc
penetr
viral
core
cell
colman
et
al
dimitrov
lai
et
al
coronaviru
cellsurfac
receptor
identifi
aminopeptidas
n
apn
shown
receptor
canin
coronaviru
felin
infecti
periton
viru
porcin
epidem
diarrhea
viru
porcin
transmiss
gastroenter
viru
group
coronavirus
delma
et
al
oh
et
al
yeager
et
al
member
pleiotrop
famili
carcinoembryon
antigencel
adhes
molecul
identifi
receptor
group
pathogen
murin
hepat
viru
william
et
al
wherea
bovin
group
coronavirus
bind
sialic
acid
holm
et
al
fulllength
partial
protein
differ
sarscov
isol
clone
express
character
sever
research
group
month
discoveri
viru
bisht
et
al
li
et
al
simmon
et
al
wong
et
al
xiao
et
al
sarscov
protein
found
molecular
weight
kd
page
analys
protein
suggest
undergo
posttransl
modif
sinc
determin
weight
much
higher
molecular
weight
predict
amino
acid
sequenc
bisht
et
al
xiao
et
al
sarscov
protein
typic
class
fusion
protein
howev
littl
similar
amino
acid
sequenc
protein
sarscov
coronavir
protein
furthermor
contrast
protein
sarscov
protein
cleav
host
cell
proteas
subunit
although
domain
correspond
identifi
marra
et
al
rota
et
al
xiao
et
al
sarscov
protein
alon
suffici
mediat
viruscel
fusion
sarscov
domain
identifi
receptorbind
region
attach
protein
wherea
domain
found
mediat
fusion
host
cell
membran
li
et
al
xiao
et
al
howev
imposs
predict
cellsurfac
receptor
sarscov
might
util
fuse
host
cell
part
limit
sequenc
homolog
sarscov
domain
protein
coronavirus
fact
observ
sever
lethal
sarscov
infect
elucid
limit
sequenc
homolog
protein
suggest
receptor
differ
known
coronaviru
receptor
laboratori
employ
straightforward
approach
coimmunoprecipit
identifi
sarscov
cell
surfac
receptor
li
et
al
first
creat
codonoptim
gene
encod
sarscov
urbani
strain
domain
amino
acid
residu
fuse
fc
domain
human
codon
optim
result
markedli
enhanc
express
level
compar
wildtyp
protein
construct
bound
surfac
african
green
monkey
kidney
vero
cell
highli
suscept
sarscov
infect
high
affin
human
embryon
kidney
hek
cell
sarscov
replic
poorli
li
et
al
encourag
observ
lyse
metabol
label
vero
cell
deterg
pb
incub
lysat
sarscov
sepharoseprotein
bead
bound
protein
separ
page
individu
band
present
control
reaction
analyz
trypsin
digest
mass
spectrometri
angiotensinconvert
enzym
li
et
al
solubl
form
close
relat
block
bind
surfac
vero
cell
antibodi
block
sarscov
strain
urbani
replic
vero
cell
sarscov
replic
effici
hek
cell
transfect
last
demonstr
syncytia
format
proteinexpress
hek
cell
hek
cell
express
li
et
al
suggest
syncytia
observ
sarscovinfect
vero
cell
nonhuman
primat
patient
fouchier
et
al
kuiken
et
al
develop
interact
commerci
avail
antibodi
target
block
syncytia
format
li
et
al
stabli
hek
cell
transduc
proteinpseudotyp
simian
immunodefici
viru
cell
consist
idea
abund
cell
surfac
determin
identifi
promis
sarscov
receptor
candid
human
effici
sarscov
infect
other
identifi
recombin
human
singlechain
variabl
region
fragment
scfv
sarscov
strain
domain
nonimmun
human
antibodi
librari
scfv
name
scfv
inhibit
format
syncytia
hek
cell
express
hek
cell
express
protein
also
effici
neutral
infect
vero
cell
sarscov
urbani
strain
scfv
compet
solubl
form
associ
domain
found
bind
high
affin
k
nm
plasmon
reson
studi
human
form
scfv
bound
higher
affin
k
nm
neutral
urbani
strain
sarscov
higher
effici
scfv
sui
et
al
also
independ
identifi
sarscov
receptor
anoth
group
transduc
hela
cell
retroviru
cdna
librari
vero
cell
follow
flow
cytometri
select
transduc
cell
bound
purifi
protein
residu
carboxymetalloproteas
relat
coronaviru
receptor
distantli
relat
ace
discov
donoghu
et
al
tipni
et
al
enzym
type
transmembran
protein
singl
metalloproteas
activ
site
hexxh
zinc
bind
motif
donoghu
et
al
tipni
et
al
physiolog
function
remain
enigmat
enzym
shown
cleav
varieti
regulatori
peptid
vitro
among
angiotensin
ii
desargbradykinin
kinetensin
neurotensin
donoghu
et
al
vicker
et
al
cleavag
product
shown
potent
vasodil
antidiuret
effect
find
gave
rise
theori
counterbal
action
mediat
vasoconstrict
yagil
et
al
furthermor
target
disrupt
mice
result
sever
cardiac
contractil
defect
crackow
et
al
despit
high
express
level
low
level
sarscov
replic
found
cardiac
tissu
farca
et
al
find
suggest
anoth
receptor
coreceptor
necessari
success
cellular
infect
sarscov
inde
dcsignr
lsign
identifi
molecul
facilit
sarscov
infect
jeffer
et
al
marzi
et
al
howev
tissu
distribut
match
tissu
tropism
sarscov
exampl
high
level
express
detect
gastrointestin
tract
kidney
lung
donoghu
et
al
ham
et
al
harmer
et
al
target
sarscov
ham
et
al
other
shown
level
express
differ
cell
line
correl
suscept
sarscov
infect
hattermann
et
al
hofmann
et
al
suscept
transduct
lentivir
pseudotyp
carri
sarscov
protein
transfect
sarscovrefractori
cell
line
confer
suscept
infect
mossel
et
al
taken
togeth
result
impli
major
cellsurfac
receptor
sarscov
also
suggest
tissu
express
rather
refractori
sarscov
infect
limit
viru
replic
step
follow
interact
protein
other
also
determin
receptorbind
domain
rbd
sarscov
wong
et
al
consist
amino
acid
residu
see
figur
fc
fusion
protein
rbdig
bound
effici
fulllength
least
two
amino
acid
residu
glutam
acid
aspart
acid
crucial
interact
hek
cell
stabli
express
rbdig
block
transduct
cell
proteinpseudotyp
simian
immunodefici
viru
lower
concentr
ic
nm
fulllength
ic
rbdig
combin
freund
complet
adjuv
induc
strong
antibodi
respons
intraderm
immun
nzw
rabbit
antibodi
complet
inhibit
infect
vero
cell
tcid
sarscov
serum
dilut
block
interact
commerci
avail
et
al
similarli
immun
mice
rabbit
inactiv
sarscov
induc
antibodi
specif
recogn
rbd
block
interact
prevent
cell
transduct
proteinpseudotyp
et
al
attenu
modifi
vaccinia
viru
ankara
express
sarscov
strain
protein
induc
neutral
antibodi
immun
balbc
mice
rabbit
chines
rhesu
macaqu
antibodi
demonstr
recogn
neutral
epitop
consist
protein
amino
acid
residu
strongli
suggest
rbd
target
antibodi
fact
rbdig
could
absorb
major
neutral
antibodi
incub
antibodycontain
sera
final
conform
sensit
epitop
recogn
potent
sarscovneutr
antibodi
sui
et
al
identifi
protein
ntermin
amino
acid
residu
overlap
neutral
antibodi
target
receptorbind
domain
protein
viru
neutral
occur
mainli
interrupt
interact
delet
studi
demonstr
cytoplasm
domain
import
interact
addit
solubl
consist
ectodomain
block
transduct
proteinpseudotyp
demonstr
enzymat
inact
variant
contain
two
asparagin
residu
place
activesit
histidin
residu
still
bind
protein
facilit
entri
proteinpseudotyp
lentivirus
find
demonstr
proteolyt
activ
play
role
sarscov
cell
penetr
also
bind
protein
alter
enzymat
activ
moor
et
al
final
show
purifi
prevent
hek
cell
transduct
sproteinpseudotyp
simian
immunodefici
viru
ic
nm
block
infect
cell
infecti
sarscov
sarscovneutr
antibodi
block
hek
cell
transduct
pseudotyp
carri
sarscov
strain
strain
protein
prevent
transduct
pseudotyp
carri
strain
protein
observ
impli
rbd
differ
key
residu
suggest
possibl
differ
rbd
differ
affin
differ
speci
comparison
rbd
amino
acid
sequenc
report
distinct
sarset
al
combin
result
strongli
support
idea
sarscov
rbd
scfv
precipit
rbdig
effici
protein
sui
tabl
amino
acid
chang
receptor
bind
domain
rbd
spike
protein
variou
sarscov
sarscovlik
isol
accord
tissu
distribut
murin
rat
found
compar
human
gembardt
et
al
komatsu
et
al
howev
found
murin
bound
less
effici
sarscov
domain
support
proteinmedi
infect
less
effici
human
likewis
hek
cell
syncytia
format
occur
much
higher
effici
human
rather
murin
express
murin
nih
cell
express
human
support
sarscov
replic
level
one
magnitud
higher
cell
express
murin
rat
hand
support
proteinmedi
infect
hek
cell
syncytia
format
interestingli
exchang
four
amino
acid
residu
rat
equival
residu
found
human
residu
transform
rat
effici
receptor
sarscov
domain
civet
reveal
amino
acid
chang
see
tabl
crystal
structur
shown
orient
ctermin
collectrin
domain
downward
view
front
cleft
bear
enzymat
activ
site
residu
rat
whose
alter
correspond
human
residu
convert
rat
effici
sarscov
receptor
shown
dark
gray
sphere
human
residu
whose
alter
substanti
decreas
associ
shown
light
gray
sphere
residu
whose
alter
affect
associ
shown
stick
figur
format
lowresolut
electron
densiti
associ
collectrin
domain
repres
small
base
figur
lower
panel
view
ident
upper
panel
except
molecul
rotat
degre
horizont
axi
present
virusey
view
find
led
us
hypothes
host
tropism
sarscov
sarscovlik
virus
well
sever
induc
diseas
differ
speci
might
depend
rbd
mutat
experi
laboratori
support
hypothesi
shown
figur
local
proteinbind
domain
loop
locat
afar
enzym
activ
site
within
catalyt
domain
dale
et
al
towler
et
al
protein
differ
sarscov
strain
isol
outbreak
well
protein
sarscovlik
virus
isol
himalayan
palm
civet
bound
himalayan
palm
civet
effici
howev
shown
figur
latter
two
protein
bound
human
much
less
effici
protein
viru
caus
initi
outbreak
exchang
specif
residu
human
found
himalayan
palm
civet
markedli
enhanc
bind
protein
himalayan
palm
civet
virus
likewis
exchang
residu
protein
rbd
residu
found
protein
viru
isol
outbreak
see
tabl
increas
bind
effici
human
collect
data
suggest
appar
lack
sever
humantohuman
transmiss
associ
small
sar
outbreak
part
due
incomplet
adapt
associ
viru
isol
human
adapt
mediat
mainli
two
amino
acid
residu
result
also
provid
biochem
support
hypothesi
palm
civet
sourc
sarscov
tissu
tropism
human
coronaviru
sarscov
seem
ident
recent
use
pseudotyp
shown
also
use
cellentri
receptor
albeit
lower
affin
hofmann
et
al
find
surpris
spike
protein
two
virus
share
amino
acid
ident
addit
find
suggest
sar
caus
unidentifi
virul
factor
sarscov
encod
rel
harmless
genom
clearli
studi
entri
mechan
necessari
hofmann
et
al
figur
differenti
associ
three
protein
human
palmcivet
cell
transfect
plasmid
encod
human
palmcivet
radiolabel
lyse
protein
immunoprecipit
antibodi
recogn
tag
present
carboxyterminu
receptor
variant
contain
domain
gd
protein
analyz
sdspage
sarscov
isol
human
infect
outbreak
gd
small
outbreak
result
mild
symptom
humantohuman
transmiss
palm
civet
b
experi
similar
except
sprotein
residu
compris
receptorbind
domain
rbd
indic
protein
fuse
fc
domain
human
rbdig
use
immunoprecipit
human
palmcivet
bottom
panel
show
coomassiestain
sdspage
gel
individu
rbd
use
experi
first
recogn
appear
sarscov
quickli
spread
global
among
human
popul
caus
novel
sever
diseas
peopl
lethal
almost
cherri
one
natur
outbreak
sar
record
sinc
emerg
four
peopl
infect
surviv
fleck
gave
rise
notion
sarscov
disappear
futur
outbreak
sar
like
research
fund
would
better
spent
pathogen
howev
natur
reservoir
sarscov
still
identifi
himalayan
palm
civet
suspect
carrier
viru
anim
associ
epidemiolog
mani
human
sar
case
experi
himalayan
palm
civet
shown
suscept
sarscov
infect
replic
howev
anim
like
domest
cat
ferret
also
shown
suscept
martina
et
al
wu
et
al
chines
ferret
badger
racoon
dog
suggest
natur
carrier
sarscovlik
virus
guan
et
al
experi
demonstr
two
amino
acid
residu
receptor
bind
domain
sarscov
spike
protein
determin
effici
bind
cellsurfac
receptor
two
residu
variabl
differ
anim
henc
allow
prohibit
sarscov
cell
entri
find
suggest
mutat
need
occur
natur
circul
sarscov
sarscovlik
viru
unknown
reservoir
allow
crossspeci
transmiss
human
sar
outbreak
hand
experi
perform
laboratori
also
suggest
specif
prevent
treatment
sar
outbreak
could
achiev
review
present
strong
support
role
sole
cellentri
determin
sarscov
describ
abil
neutral
antibodi
disrupt
interact
hattermann
et
al
li
et
al
mossel
et
al
nie
et
al
sui
et
al
wang
et
al
result
suggest
futur
vaccin
candid
elicit
antibodi
respons
protein
receptor
bind
domain
term
treatment
sever
promis
research
direct
could
taken
first
base
find
sarscov
protein
receptor
bind
domain
prevent
cell
transduct
proteinpseudotyp
lentivirus
modifi
polypeptid
resembl
protein
fragment
could
develop
bind
prevent
bind
sarscov
host
cell
second
develop
specif
inhibitor
contain
protein
fragment
feasibl
exampl
identif
inhibitor
prevent
bind
sarscov
proteolyt
activ
recent
report
huentelman
et
al
howev
inhibitor
like
associ
sever
side
effect
sinc
interrupt
physiolog
yet
unknown
function
demonstr
sarscov
bind
site
remot
enzym
activ
site
show
sarscov
bind
interfer
enzymat
activ
moor
et
al
henc
better
inhibitor
could
identifi
block
interact
alter
physiolog
function
last
shown
solubl
prevent
transduct
cell
sarscov
proteinpseudotyp
lentivirus
li
et
al
suggest
polypeptid
consist
sarscovbind
domain
could
use
therapeut
shown
enzymat
inact
still
abl
interrupt
proteinmedi
entri
lentivir
pseudotyp
allow
synthesi
variant
fragment
thereof
would
prevent
sarscov
infect
would
interfer
predict
role
regul
blood
pressur
yagil
et
al
surpris
discoveri
receptor
anoth
coronaviru
rais
question
whether
antivir
vaccin
could
develop
target
viru
sarscov
time
evid
necessari
defin
receptorbind
domain
spike
protein
interact
region
find
answer
